
In this episode of Discovery Matters, we explore both sides of the gene‑editing coin: the tools that cut DNA and the technologies that safely deliver them where they need to go.
First, we’re joined by Dr. Stephan Riesenberg from the Max Planck Institute for Evolutionary Anthropology in Leipzig, who takes us inside the world of synthetic guide RNAs. Then, we zoom out to delivery and analytics with Adam Crowe, Senior Manager of Nanomedicine Analytical Development at Cytiva. Adam reveals why lipid nanoparticles (LNPs) are both powerful and incredibly complex, and how cutting‑edge analytics are critical for turning promising gene‑editing tools into real medicines.
Flere episoder fra "Discovery Matters"



Gå ikke glip af nogen episoder af “Discovery Matters” - abonnér på podcasten med gratisapp GetPodcast.








